A dramatic shift in R&D toward patient safety has taken place in the CT industry, a shift most clearly seen in efforts to reduce patient radiation dose. Iterative reconstruction algorithms are a prominent fixture at the ISCT meeting this year, as they and their future development are increasingly seen as providing the means to cut dose, while maintaining or even boosting image quality.
A dramatic shift in R&D toward patient safety has taken place in the CT industry, a shift most clearly seen in efforts to reduce patient radiation dose. Iterative reconstruction algorithms are a prominent fixture at the ISCT meeting this year, as they and their future development are increasingly seen as providing the means to cut dose, while maintaining or even boosting image quality.
In the past, vendors have emphasized image quality alone, looking for ways to improve diagnostic confidence or add clinical applications. But with increasing attention being paid to patient dose, vendors have sought to leverage this software to maintain the current benchmark of image quality and reduce dose.
They have documented that iterative reconstruction algorithms can be used to clean up noisy images, producing scans of the same image quality as before, but with less radiation. GE Healthcare pioneered this approach, unveiling the idea at RSNA 2008 with its Adaptive Statistical Iterative Reconstruction product. Dose reductions of 50% or more have since been demonstrated in clinical use, according to the company.
More recently, Siemens and Philips have followed suit, Siemens through its IRIS (Iterative Reconstruction in Image Space) and Philips through its iDose. Toshiba is also developing an iterative reconstruction algorithm. GE is developing a next-generation Model-Based Iterative Reconstruction.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.